|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 37.92 EUR | -0.67% |
|
+4.37% | -6.80% |
| Jun. 05 | Deutsche Börse News: Bonds: 'Sideways Market Ahead of ECB Meeting' | DP |
| Jun. 03 | Fresenius Medical Care Launches Kinexus Worldwide, A Unified Digital Platform to Support Home Dialysis | CI |
Business description: Fresenius Medical Care AG
- clinical care services (75.2%): operated, at the end of 2025, 3,601 institutions;
- manufacturing of dialyzers and related products (24.8%): hemo-dialysis and pediatric dialysis machines, etc. The group also offers therapies accompanied by care and treatment for dialysis patients.
Number of employees: 108,165
Sales by Activity: Fresenius Medical Care AG
| Fiscal Period: December | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
Care Delivery (Excl. Value-Based Care) | - | - | - | - | 13.74B |
Care Delivery | - | - | 15.58B | 15.28B | - |
Europe, Middle East and Africa (EMEA) | 2.76B | 2.85B | - | - | - |
Latin America | 703M | 798M | - | - | - |
Asia-Pacific | 2.01B | 2.15B | - | - | - |
North America | 12.12B | 13.57B | - | - | - |
Care Enablement | - | - | 5.35B | 5.56B | 5.48B |
Value-Based Care | - | - | - | - | 2.25B |
Corporate | 20.8M | 27.99M | - | - | - |
Inter-Segment Eliminations | - | - | -1.47B | -1.5B | -1.83B |
Geographical breakdown of sales: Fresenius Medical Care AG
| Fiscal Period: December | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
United States | - | - | 13.51B | 13.67B | 14.18B |
Rest of the World | 5.02B | 5.34B | 5.46B | 5.19B | 4.95B |
Germany | 511M | 487M | 484M | 479M | 495M |
North America | 12.09B | 13.57B | - | - | - |
Executive Committee: Fresenius Medical Care AG
| Manager | Title | Age | Since |
|---|---|---|---|
Helen Giza
CEO | Chief Executive Officer | 58 | 2022-12-05 |
Martin Fischer
DFI | Director of Finance/CFO | 48 | 2023-09-30 |
| Chief Tech/Sci/R&D Officer | 56 | 2025-12-31 | |
Jörg Häring
CMP | Compliance Officer | 56 | 2024-05-31 |
| Corporate Officer/Principal | 58 | - |
Composition of the Board of Directors: Fresenius Medical Care AG
| Director | Title | Age | Since |
|---|---|---|---|
Pascale Witz
BRD | Director/Board Member | 59 | 2016-05-11 |
A. Sorensen
BRD | Director/Board Member | 64 | 2021-05-19 |
Michael Sen
CHM | Chairman | 57 | 2023-07-13 |
Shervin Korangy
BRD | Director/Board Member | 51 | 2023-07-13 |
Marcus Kuhnert
BRD | Director/Board Member | 58 | 2023-07-13 |
Sara Hennicken
BRD | Director/Board Member | 46 | 2023-07-13 |
Stefanie Lang
BRD | Director/Board Member | 57 | 2024-01-25 |
| Director/Board Member | 56 | 2024-01-25 | |
Frank Prescher
BRD | Director/Board Member | 63 | 2024-01-25 |
Ralf Erkens
BRD | Director/Board Member | 61 | 2024-01-25 |
Holdings: Fresenius Medical Care AG
| Name | Equities | % | Valuation |
|---|---|---|---|
HUMACYTE, INC. 8.25% | 18,312,735 | 8.25% | 24 M $ |
Company details: Fresenius Medical Care AG
Fresenius Medical Care AG
Else-Kröner-Strasse 1
61352, Bad Homburg
+49 6172 609 0
http://www.freseniusmedicalcare.com/de
Group companies: Fresenius Medical Care AG
| Name | Category and Sector |
|---|---|
Fresenius Management Services, Inc.
 Fresenius Management Services, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management services |
Miscellaneous Commercial Services
|
Fresenius Management Services, Inc.
Fresenius Management Services, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management services |
Miscellaneous Commercial Services
|
Fresenius Medical Care SSC Sp zoo | |
Fresenius Medical Care SSC Sp zoo | |
Fresenius Medical Care Reinsurance Co. (Cayman) Ltd. |
Other Healthcare Facilities & Services
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.67% | +4.37% | -24.17% | -11.38% | 11.84B | |
| +1.17% | +5.44% | +50.88% | +34.21% | 122B | |
| +2.85% | -1.69% | -3.18% | +36.05% | 82.55B | |
| -0.51% | +4.39% | -15.76% | +42.33% | 24.23B | |
| +2.13% | +2.77% | +14.88% | +48.47% | 22.17B | |
| -0.47% | -1.98% | -17.49% | -20.57% | 19.97B | |
| -1.06% | -3.70% | -8.59% | +1.20% | 14.02B | |
| +0.43% | -7.56% | -5.48% | +117.12% | 13.96B | |
| -0.01% | -1.13% | +39.35% | +91.09% | 12.34B | |
| +2.96% | +7.19% | -15.75% | +80.51% | 9.98B | |
| Average | +0.69% | -0.22% | +1.47% | +41.90% | 33.35B | |
| Weighted average by Cap. | +1.25% | +1.40% | +16.22% | +36.88% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- FME Stock
- Company Fresenius Medical Care AG
Select your edition
All financial news and data tailored to specific country editions
